Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2003
05/28/2003CN1420775A Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation
05/28/2003CN1419938A Fusion anticaries DNA vaccine and prepring method thereof
05/28/2003CN1419937A Immune anticaries DNA vaccine, preparing method and use thereof
05/28/2003CN1109749C Pressure-mediated intracellular delivery of molecules or microparticles
05/27/2003US6570004 dapE gene on Helicobacter pylori and dapE− mutant strains of Helicobacter pylori
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6569995 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
05/27/2003US6569992 Protein for use in the treatment of immunological, liver, reproductive and infectious disorders
05/27/2003US6569679 Recombinant viral vector capable of expressing a gene product that activates a non-cytotoxic compound into a toxic product; use in treatment of viral diseases, cancer, genetic diseases
05/27/2003US6569677 Viral genome mutations involving the recognition and binding of natural cell receptors for adenoviruses; use in human gene therapy applications
05/27/2003US6569666 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
05/27/2003US6569665 Genetic engineering; enzymatic inhibitor screening; use of calpain inhibitors in treatment of neurodegenerative disease
05/27/2003US6569661 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
05/27/2003US6569655 For use in therapeutics, diagnostics, and as research tools
05/27/2003US6569643 Expression vector for use as tool in genetic engineering
05/27/2003US6569450 Lipid-conjugated polyamide compounds and related compositions and methods thereof
05/27/2003US6569428 For regulating angiogenesis; nucleic acid encoding an endothelial cell mitogen and endothelial cell progenitors, where the EC progenitors are CD34+, Flk-1+, and tie-2+
05/27/2003US6569426 Tresyl-monomethoxypolyethylene glycol-modified viruses having viral infectivity
05/27/2003US6569423 Regenerating nervous tissue by contacting tissue with an effective amount of Schwann cells expressing transcription factor Delta SCIP
05/27/2003CA2273855C Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042387A1 Novel hair keratin-associated proteins
05/22/2003WO2003042368A2 Methods of expressing lim mineralization protein in non-osseous cells
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003042358A2 Methods of using 48149, a human aminopeptidase family member
05/22/2003WO2003042246A2 Inhibitors of the notch signalling pathway for use in the treatment of cancer
05/22/2003WO2003042245A2 Growth hormone variations in humans and their uses
05/22/2003WO2003042244A2 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003WO2003020763A3 Soluble t cell receptor
05/22/2003WO2003008554A3 Methods and compositions for cell therapy
05/22/2003WO2002102987A3 Methods and compositions based on protein interactions with mastermind
05/22/2003WO2002097116A3 Delivery system for nucleic acids
05/22/2003WO2002081625A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
05/22/2003WO2002072754A3 Mva expressing modified hiv envelope, gag, and pol genes
05/22/2003WO2002068653A3 Tri-hybrid melanoma antigen
05/22/2003WO2002051430A3 Methods of modulating toll-related receptor (trr) signaling
05/22/2003WO2002036780A3 Stearoyl-coa desaturase gene promoter
05/22/2003WO2002031180A3 Flea peritrophin nucleic acid molecules, proteins and uses thereof
05/22/2003WO2002029050A3 Regulation of human secretin receptor-like gpcr
05/22/2003WO2002010389A3 Human ion channel proteins and polynucleotides encoding the same
05/22/2003WO2001070941A9 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
05/22/2003US20030097670 For producing and isolating homogeneous proteins
05/22/2003US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders
05/22/2003US20030096787 Comprising the ITR sequences, a sequence permitting the encapsulation, a heterologous DNA sequence, and in which the E1 gene and at least one of the E2, E4 and L1-L5 genes is non-functional
05/22/2003US20030096786 Methods of treating neurodegenerative or myelination disorders using prosaposin-derived peptides
05/22/2003US20030096785 Antisense agents to nucleic acids encoding human proteins (G protein-coupled receptors designated GPR12 and GPR3), which are expressed in the hypothalamus, to suppress hunger; antibodies, drug screening
05/22/2003US20030096784 Oligoribonucleotides and oligoribonucleosides that have subsequences of 2'-pentoribofuranosyl nucleosides that activate dsRNase (double stranded RNAase)
05/22/2003US20030096783 21132, a human G-protein coupled receptor family member and uses therefor
05/22/2003US20030096782 Expression profiling in the intact human heart
05/22/2003US20030096781 Interleukin-8 (IL-8); antisense nucleotide targeted to IL-8 for rapid treatment without the associated cumulative toxicity of conventional treatments
05/22/2003US20030096780 High affinity IP3-binding polypeptide
05/22/2003US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
05/22/2003US20030096778 Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
05/22/2003US20030096774 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
05/22/2003US20030096771 8-50 nucleobases targeted to a nucleic acid molecule encoding hormone-sensitive lipase to hybridize with and inhibit expression
05/22/2003US20030096769 Genetic molecules capable of modulating growth factor interaction with its receptor on epidermal keratinocytes
05/22/2003US20030096768 Treating the cell with a Receptor Internalization and Degradation (RID) protein complex; antitumor agents; treating degenerative and immune disorders
05/22/2003US20030096767 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed
05/22/2003US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096755 Suppression of inhibitors
05/22/2003US20030096747 Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
05/22/2003US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096739 Nuclear receptor-mediated introduction of a PNA into cell nuclei
05/22/2003US20030096415 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR)
05/22/2003US20030096398 Artificial nucleotide sequences for use as tools in gene therapy
05/22/2003US20030096397 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
05/22/2003US20030096354 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders
05/22/2003US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096344 Therapeutic agent for use in the diagnosis and treatment of cancer and cell proliferative disorders
05/22/2003US20030096287 Oligonucleotide for use as diagnostic tool in genetic engineering
05/22/2003US20030096286 Oligoribonucleotides and ribonucleases for cleaving RNA
05/22/2003US20030096270 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
05/22/2003US20030096266 Hydrophobic biopolymer for use in the treatment of infections, blood, inflammatory and muscular disorders
05/22/2003US20030096247 Human cDNAs and proteins and uses thereof
05/22/2003US20030096236 Determining common functional alleles in a population and uses therefore
05/22/2003US20030096016 Methods of kidney transplantation utilizing developing nephric tissue
05/22/2003US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof
05/22/2003US20030095972 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152
05/22/2003US20030095971 Compositions and methods for WT1 specific immunotherapy
05/22/2003US20030095962 Chimeric cell-surface receptors that undergo antigen-induced association
05/22/2003US20030095956 Methods of proliferating undifferentiated neural cells
05/22/2003US20030095954 Growth factor gene fused with secretory signal sequence is introduced into fibroblasts ex-vivo using adenovirus vector; infecting cultured non-hematocytes with the vector; administering the cells
05/22/2003US20030095949 Introducing into cells viral particles or vector that comprise a polynucleotide encoding a serum protein.
05/22/2003US20030095948 Lentiviral vector construct for transferring nucleotide sequences; comprises transcription regulatory sequences of one or more genes preferentially expressed in endothelial cells of mammals.
05/22/2003US20030095947 Compositions and methods for elimination of unwanted cells
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2467052A1 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003CA2466769A1 Methods of expressing lim mineralization protein in non-osseous cells
05/22/2003CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2463639A1 Growth hormone variations in humans and their uses
05/21/2003WO2004041156A2 Method for determining sensitivity to a bacteriophage
05/21/2003EP1312679A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312678A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312674A1 Allosteric ribozymes and uses thereof
05/21/2003EP1311704A2 Novel target genes for diseases of the heart
05/21/2003EP1311699A2 Adeno-associated virus-mediated delivery of angiogenic factors
05/21/2003EP1311694A1 Pyruvate:nadp+ oxidoreductase and uses thereof
05/21/2003EP1311691A2 Method and compositions for promoting osteogenesis
05/21/2003EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
1 ... 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 ... 870